argenx SE (ARGNF)
USD 697.42
(0.33%)
USD 697.42
(0.33%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 20 Million USD | 60.95% |
| 2022 | 12.42 Million USD | 8.38% |
| 2021 | 11.46 Million USD | 18.47% |
| 2020 | 9.67 Million EUR | 32.62% |
| 2019 | 7.29 Million EUR | 0.0% |
| 2018 | - EUR | 0.0% |
| 2017 | - EUR | 0.0% |
| 2016 | - EUR | 0.0% |
| 2015 | - EUR | 0.0% |
| 2014 | - EUR | 0.0% |
| 2013 | - EUR | -100.0% |
| 2012 | 2.23 Million EUR | 2.04% |
| 2011 | 2.19 Million EUR | 0.0% |
| 2010 | - EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 33.96 Million USD | 0.0% |
| 2024 Q1 | - USD | -100.0% |
| 2023 FY | 20 Million USD | 60.95% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q2 | 11.24 Million USD | 0.0% |
| 2023 Q3 | - USD | -100.0% |
| 2023 Q4 | 20 Million USD | 0.0% |
| 2022 Q4 | 12.42 Million USD | 0.0% |
| 2022 Q2 | 9.7 Million USD | 0.0% |
| 2022 FY | 12.42 Million USD | 8.38% |
| 2022 Q3 | - USD | -100.0% |
| 2021 Q2 | 7.88 Million USD | 0.0% |
| 2021 FY | 11.46 Million USD | 18.47% |
| 2021 Q4 | 11.46 Million USD | 0.0% |
| 2020 Q2 | 7.78 Million EUR | 0.0% |
| 2020 FY | 9.67 Million EUR | 32.62% |
| 2020 Q4 | 9.67 Million EUR | 0.0% |
| 2019 FY | 7.29 Million EUR | 0.0% |
| 2019 Q4 | 6.51 Million EUR | 0.0% |
| 2019 Q2 | 4.19 Million EUR | 0.0% |
| 2018 FY | - EUR | 0.0% |
| 2018 Q4 | - EUR | 0.0% |
| 2018 Q2 | - EUR | 0.0% |
| 2017 Q2 | - EUR | 0.0% |
| 2017 FY | - EUR | 0.0% |
| 2017 Q4 | - EUR | 0.0% |
| 2016 Q4 | - EUR | 0.0% |
| 2016 Q2 | - EUR | 0.0% |
| 2016 FY | - EUR | 0.0% |
| 2015 Q4 | - EUR | 0.0% |
| 2015 FY | - EUR | 0.0% |
| 2015 Q2 | - EUR | 0.0% |
| 2014 Q1 | - EUR | 0.0% |
| 2014 Q4 | - EUR | 0.0% |
| 2014 Q2 | - EUR | 0.0% |
| 2014 FY | - EUR | 0.0% |
| 2013 Q4 | - EUR | 0.0% |
| 2013 FY | - EUR | -100.0% |
| 2012 FY | 2.23 Million EUR | 2.04% |
| 2011 FY | 2.19 Million EUR | 0.0% |
| 2010 FY | - EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 20.32 Million USD | 1.614% |
| Skye Bioscience, Inc. | 4.61 Million USD | -333.344% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | 32.812% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -16226.531% |
| Qrons Inc. | 351.84 Thousand USD | -5584.289% |
| Adynxx, Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 4.71 Million USD | -324.501% |
| CSL Limited | 12.18 Billion USD | 99.836% |
| Evofem Biosciences, Inc. | 43.37 Million USD | 53.888% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -240.652% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -2544.789% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 56.102% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Rebus Holdings, Inc. | 310 Thousand USD | -6351.613% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -3074.215% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -77663.521% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | 51.46% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -385.206% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -4876.994% |
| SQZ Biotechnologies Company | 27.47 Million USD | 27.196% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -759.862% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -2009.102% |
| Mesoblast Limited | 118.7 Million USD | 83.151% |
| Marizyme, Inc. | 18.71 Million USD | -6.852% |
| Genus plc | 233.1 Million USD | 91.42% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -582.503% |
| Pharming Group N.V. | 171.54 Million USD | 88.341% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -2152.09% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -1388.556% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -2566.667% |
| ContraFect Corporation | 2.88 Million USD | -594.203% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -14661.564% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -1282.821% |
| IMV Inc. | 28.88 Million USD | 30.757% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -253.46% |
| MultiCell Technologies, Inc. | 202.58 USD | -9872542.907% |
| ONE Bio Corp. | 19.71 Million USD | -1.445% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 65.211% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.49 Million USD | -1238.015% |
| Q BioMed Inc. | 4.1 Million USD | -386.62% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | 39.579% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -1528.186% |
| Biomind Labs Inc. | 735.54 Thousand USD | -2619.083% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 70.433% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -560.897% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -53.882% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -5460.034% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -14032.478% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -785.59% |
| GB Sciences, Inc. | 1.75 Million USD | -1036.811% |
| Alpha Cognition Inc. | 1.22 Million USD | -1538.845% |
| HST Global, Inc. | 98.31 Thousand USD | -20241.948% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -7941.171% |
| Halberd Corporation | 150 Thousand USD | -13233.333% |
| Enzolytics Inc. | 996.33 Thousand USD | -1907.351% |
| Agentix Corp. | 50 Thousand USD | -39900.0% |
| Resverlogix Corp. | 6.49 Million USD | -208.119% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -7724.971% |
| MetaStat, Inc. | - USD | -Infinity% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -182.773% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -638.361% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -195499.022% |
| Genscript Biotech Corporation | 417.73 Million USD | 95.212% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -9869.295% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -734.124% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -8622.54% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -13354.061% |
| Kadimastem Ltd | 891.22 Thousand USD | -2144.1% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -7894.18% |
| LadRx Corporation | 33.6 Thousand USD | -59413.182% |
| Cell Source, Inc. | 9.25 Million USD | -116.119% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -2544.789% |
| NovAccess Global Inc. | 2.19 Million USD | -809.14% |
| Affymax, Inc. | - USD | -Infinity% |
| Itoco Inc. | 228.37 Thousand USD | -8657.449% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -9379.796% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -301.365% |
| Mobile Lads Corp. | 484.28 Thousand USD | -4029.808% |
| CytoDyn Inc. | 30.07 Million USD | 33.502% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -155.756% |
| SYBLEU INC | 477.5 Thousand USD | -4088.482% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -322.361% |
| International Stem Cell Corporation | 4.17 Million USD | -378.698% |
| Bioxytran, Inc. | 1.92 Million USD | -938.961% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -31944.606% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -817.053% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -140.5% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -132.964% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -1185.778% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -7362.687% |
| Neutra Corp. | 54.15 Thousand USD | -36830.349% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -992.896% |
| PureTech Health plc | 25.51 Million USD | 21.606% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -1533.685% |
| IXICO plc | 472.02 Thousand USD | -4137.082% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -29.024% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 67.878% |
| CSL Limited | 12.18 Billion USD | 99.836% |
| Cellectis S.A. | 92.77 Million USD | 78.443% |